Projects at the PCT Centre
2018, Pilot study – Uppsala University
2019, Combination treatment study – Lund University
2019, Tumour treatment study – Uppsala University
2019, Combination treatment study – Uppsala University
2020, Combination treatment study – Beactica
2021, Side effects of treatment study – Karolinska Institute
2021, Combination treatment study – Beactica
2021, Flank tumour study – Uppsala University
2021, Tumour study – Karolinska Institute
2021, Preclinical drug development study – SciLifeLab DDD
2022, Glioma standard treatment pilot – Beactica/Uppsala University
2022, Combination treatment study – Beactica
2022, Flank xenograft treatment study – Karolinska Institute
2022, Tolerability study, brain tumor treatment – Uppsala University
2022, Hollow fiber evaluation – Uppsala University
2023, Flank xenograft treatment study – Uppsala University
2023, Irradiation study – Uppsala University
2023, Tolerability study – Uppsala University
2023, Flank tumor evaluation – Uppsala University
2023, Flank tumor evaluation – Uppsala University
2023, Tolerability study – Uppsala University
2023, Flank tumor treatment study – Uppsala University
2023, Standard treatment of human GBM xenografts – Uppsala University
2023, Irradiation of flank tumors – Uppsala University
2023, Hollow fiber treatment study – Uppsala University
2023, Hollow fiber tolerability study – Uppsala University
2023, Heart irradiation study – Uppsala University
2023, Flank tumor pilot study – Karolinska Institute
2023, GBM combination treatment study – Uppsala University
2023, Drug evaluation with GBM standard treatment – Karolinska Institute
2023, Flank tumor combination treatment study – Uppsala University
2023, Flank tumor evaluation – Karolinska Institute
2024, Hollow fiber treatment study – Uppsala University
2024, Irradiation of flank tumors – Uppsala University
2024, Flank tumor pilot study – Karolinska Institute
2024, Flank tumor resection/metastasis pilot study – Karolinska Institute/Novartis
2024, Flank tumor treatment study – Uppsala University
2024, Mammary fat pad tumor evaluation – Uppsala University
2024, Radiation induced skeletal effects – Karolinska Institute
2024, Flank tumor treatment study – Karolinska Institute
Articles
Selvin, T., et al. 2024. Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models. SLAS Technology 29, 100232. https://doi.org/10.1016/j.slast.2024.100232.
Mainwaring, O.J. et al. 2023. ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors. Nat Commun 14, 1221. https://doi.org/10.1038/s41467-023-36847-9.
Borgenvik, A. et al. 2022. Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma. Cancer Research 82, 4586–4603. https://doi.org/10.1158/0008-5472.CAN-22-2108.
Berg, T.J. et al. 2021. The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2. Cancer Res 81, 2101–2115. https://doi.org/10.1158/0008-5472.CAN-20-1785.